Cytokinetics Stock Today
| CYTK Stock | USD 65.34 0.54 0.83% |
Performance0 of 100
| Odds Of DistressLess than 40
|
Cytokinetics is selling for 65.34 as of the 28th of April 2024. This is a 0.83 percent increase since the beginning of the trading day. The stock's last reported lowest price was 64.5. Cytokinetics has about a 40 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Cytokinetics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of February 2024 and ending today, the 28th of April 2024. Click here to learn more.
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company was incorporated in 1997 and is headquartered in South San Francisco, California. The company has 104.58 M outstanding shares of which 14.04 M shares are currently shorted by private and institutional investors with about 5.79 trading days to cover. More on Cytokinetics
Moving together with Cytokinetics Stock
| 0.73 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
Moving against Cytokinetics Stock
| 0.6 | YS | YS Biopharma | PairCorr |
| 0.5 | VANI | Vivani Medical | PairCorr |
| 0.41 | VERU | Veru Inc Financial Report 9th of May 2024 | PairCorr |
Follow Valuation Odds of Bankruptcy
Financial Report 2nd of May 2024
Cytokinetics Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cytokinetics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cytokinetics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Robert Blum |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Cytokinetics (CYTK) is traded on NASDAQ Exchange in USA. It is located in 350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 and employs 423 people. Cytokinetics is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.83 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cytokinetics's market, we take the total number of its shares issued and multiply it by Cytokinetics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cytokinetics conducts business under Biotechnology sector and is part of Health Care industry. The entity has 104.58 M outstanding shares of which 14.04 M shares are currently shorted by private and institutional investors with about 5.79 trading days to cover.
Cytokinetics currently holds about 586.03 M in cash with (414.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.22.
Check Cytokinetics Probability Of Bankruptcy
Ownership AllocationCytokinetics retains a total of 104.58 Million outstanding shares. The majority of Cytokinetics outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cytokinetics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cytokinetics. Please pay attention to any change in the institutional holdings of Cytokinetics as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Cytokinetics Ownership Details
Cytokinetics Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of Cytokinetics jumping above the current price in 90 days from now is about 87.86%. The Cytokinetics probability density function shows the probability of Cytokinetics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Cytokinetics has a beta of -0.162 suggesting as returns on the benchmark increase, returns on holding Cytokinetics are expected to decrease at a much lower rate. During a bear market, however, Cytokinetics is likely to outperform the market. Additionally, cytokinetics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Cytokinetics to move above the current price in 90 days from now is about 87.86 (This Cytokinetics probability density function shows the probability of Cytokinetics Stock to fall within a particular range of prices over 90 days) .
Cytokinetics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cytokinetics market risk premium is the additional return an investor will receive from holding Cytokinetics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cytokinetics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Cytokinetics' alpha and beta are two of the key measurements used to evaluate Cytokinetics' performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | 1.78 |
Cytokinetics Stock Against Markets
Picking the right benchmark for Cytokinetics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cytokinetics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cytokinetics is critical whether you are bullish or bearish towards Cytokinetics at a given time. Please also check how Cytokinetics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cytokinetics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Cytokinetics Corporate Directors
Cytokinetics corporate directors refer to members of a Cytokinetics board of directors. The board of directors generally takes responsibility for the Cytokinetics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Cytokinetics' board members must vote for the resolution. The Cytokinetics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Edward Kaye | Director | Profile | |
| Wendall Wierenga | Independent Director | Profile | |
| Santo Costa | Independent Director | Profile | |
| Robert Califf | Director | Profile |
How to buy Cytokinetics Stock?
Before investing in Cytokinetics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Cytokinetics. To buy Cytokinetics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Cytokinetics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Cytokinetics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Cytokinetics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Cytokinetics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Cytokinetics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Cytokinetics Stock please use our How to Invest in Cytokinetics guide.
Already Invested in Cytokinetics?
The danger of trading Cytokinetics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Cytokinetics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Cytokinetics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Cytokinetics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Cytokinetics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Cytokinetics Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Cytokinetics Stock. Highlighted below are key reports to facilitate an investment decision about Cytokinetics Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytokinetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Cytokinetics Stock analysis
When running Cytokinetics' price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytokinetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.